Growth Metrics

Xeris Biopharma Holdings (XERS) Amortizatization of Intangibles (2020 - 2025)

Xeris Biopharma Holdings' Amortizatization of Intangibles history spans 6 years, with the latest figure at -$386000.0 for Q4 2025.

  • For the quarter ending Q4 2025, Amortizatization of Intangibles fell 103.8% year-over-year to -$386000.0, compared with a TTM value of $5.2 million through Dec 2025, down 67.31%, and an annual FY2024 reading of $10.8 million, up 758.51% over the prior year.
  • Amortizatization of Intangibles for Q4 2025 was -$386000.0 at Xeris Biopharma Holdings, down from $2.7 million in the prior quarter.
  • The five-year high for Amortizatization of Intangibles was $10.2 million in Q4 2024, with the low at -$7.7 million in Q4 2022.
  • Average Amortizatization of Intangibles over 5 years is $1.1 million, with a median of $2.7 million recorded in 2022.
  • Year-over-year, Amortizatization of Intangibles skyrocketed 501.46% in 2021 and then tumbled 1501.09% in 2022.
  • Tracing XERS's Amortizatization of Intangibles over 5 years: stood at $550000.0 in 2021, then tumbled by 1501.09% to -$7.7 million in 2022, then grew by 10.86% to -$6.9 million in 2023, then skyrocketed by 248.04% to $10.2 million in 2024, then tumbled by 103.8% to -$386000.0 in 2025.
  • Per Business Quant, the three most recent readings for XERS's Amortizatization of Intangibles are -$386000.0 (Q4 2025), $2.7 million (Q3 2025), and $2.7 million (Q2 2025).